<code id='93B1856F51'></code><style id='93B1856F51'></style>
    • <acronym id='93B1856F51'></acronym>
      <center id='93B1856F51'><center id='93B1856F51'><tfoot id='93B1856F51'></tfoot></center><abbr id='93B1856F51'><dir id='93B1856F51'><tfoot id='93B1856F51'></tfoot><noframes id='93B1856F51'>

    • <optgroup id='93B1856F51'><strike id='93B1856F51'><sup id='93B1856F51'></sup></strike><code id='93B1856F51'></code></optgroup>
        1. <b id='93B1856F51'><label id='93B1856F51'><select id='93B1856F51'><dt id='93B1856F51'><span id='93B1856F51'></span></dt></select></label></b><u id='93B1856F51'></u>
          <i id='93B1856F51'><strike id='93B1856F51'><tt id='93B1856F51'><pre id='93B1856F51'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:23459
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          FDA approves Moderna’s RSV vaccine, its second licensed product
          FDA approves Moderna’s RSV vaccine, its second licensed product

          TheFDAhasapprovedModerna’sRSVvaccineforolderadults.ModernaTheFoodandDrugAdministrationonFridayapprov

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Finland to offer bird flu vaccine to select groups of people, a possible global first

          H5N1birdfluparticlesCDCandNIAIDLONDON—Finlandispreparingtooffervaccinestopeopleatriskofexposuretoana